Next, we asked if targeting the Wnt pathway via use of a PORCN inhibitor would reverse the phenomena of T cell exclusion and promote a hot TME in a clinically relevant pre-clinical murine model of ovarian cancer. The gene discussed is PORCN; the disease is ovarian cancer.